Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116554062A reveals solvent-free synthesis for high-purity Pregabalin Impurity II. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN113512085A reveals a green synthesis route for Mometasone Furoate using Compound I, offering high purity and cost reduction in pharmaceutical manufacturing.
Patent CN115819487A details a novel 4-step synthesis of 16α-hydroxyprednisolone from tetraene acetate, offering superior purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111646906A details solvent-free oxidation for high-purity aromatic ketones. Offers cost reduction in fine chemical manufacturing with superior selectivity.
Patent CN104710309A reveals a high-yield benzene-based route for loxoprofen sodium. Achieve substantial cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Efficient N-acylindole production via alkenyl carboxylates. High selectivity, metal-free, scalable for pharma intermediates.
Patent CN108752256A reveals base-catalyzed N-acylation. Offers high selectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel nickel-catalyzed asymmetric Kumada coupling method for high-purity profen intermediates. Reduces catalyst loading and improves scalability for pharmaceutical manufacturing.
Patent CN110004081A details a novel biocatalytic route for gamma-lactam. This method ensures high optical purity and offers significant supply chain cost reduction advantages.
Patent CN115851559A reveals a novel recombinant E. coli route for 3,4-DHBA. Discover cost-effective biosynthesis solutions and supply chain advantages for chiral intermediates.
Advanced bimetallic metalloporphyrin catalysts enhancing selectivity in cycloalkane oxidation, reducing diacid byproducts for efficient pharmaceutical and polymer intermediate manufacturing.
Patent CN114958938B reveals enzymatic synthesis for Paxlovid intermediate. Offers high yield and cost reduction for pharmaceutical intermediate supply chains.
Patent CN102675102A enables continuous lactate synthesis with high optical purity. Offers supply chain stability and cost reduction in fine chemical manufacturing.
Patent CN111440109A details a novel copper-catalyzed route using Bunte salts for high-purity maleimide intermediates, offering significant cost and supply chain advantages.
Patent CN111763209B details a novel Ruxolitinib synthesis avoiding expensive catalysts. Discover cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Continuous transesterification method ensures high optical purity and significant cost reduction in fine chemical intermediates manufacturing for global supply chains.
Novel antitumor intermediate synthesis via condensation. Low toxicity, high purity scalable route for pharmaceutical manufacturing and drug development.
Patent CN108358793B details a green one-pot synthesis of secondary amines from alkynes, offering significant cost reduction in API manufacturing without metal catalysts.
Novel solvent-free patent method ensures high purity DCC for peptide synthesis. Reduces cost and environmental impact for reliable pharmaceutical intermediate supply chains.
Novel patent CN105102411B enables cost-effective production of high-purity 1,1,1,5,5,5-hexafluoroacetylacetone for pharmaceutical and electronic applications.